* QF entity study published in American Society of Microbiology Journal In a collaboration led by teams from Pathology and the Genomics Core at Sidra Medicine, a study has been published about a novel point mutation in the SARS-CoV-2 genome that may affect Covid-19 testing by an FDA-approved test. The study calls to action for testing centers worldwide to monitor mutations in the virus and ensure that testing methods are up to date, and based on multiple gene targets to avoid possible false-negative results. The findings, which have been published in the Journal of Clinical Microbiology, highlight Sidra Medicine’s continuing role in supporting global efforts to tackle the pandemic and fi
Hence then, the article about sidra medicine pathology identifies new mutation that may affect covid 19 testing was published today ( ) and is available onGulf Times ( Qatar ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Sidra Medicine Pathology identifies new mutation that may affect Covid-19 testing )